Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Ranbaxy Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Feb 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - RANBAXY LABORATORIES LIMITED (RANBAXY-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

04 Mar 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Ranbaxy Laboratories Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Feb 2015 Wright Reports 56 $75.00

Ranbaxy Laboratories Limited (RANBAXY) - Financial and Strategic SWOT Analysis Review

Ranbaxy Laboratories Limited (RANBAXY) - Financial and Strategic SWOT Analysis Review Summary Ranbaxy Laboratories Limi...

04 Feb 2015 GlobalData 61 $125.00

MOSL: RANBAXY LABS (Buy) - Exceptional miss - All eyes on merger with Sun

RANBAXY LABS 3QFY15: 3QFY15 Exceptional miss; All eyes on merger with Sun (RBXY IN, Mkt Cap USD4.8b, CMP INR700, TP INR800, ...

29 Jan 2015 Motilal Oswal Securities Ltd. 12 $115.00

Ranbaxy Labs - Q3FY15 Result Update - "ACCUMULATE" - KRChoksey Research - ”Revenues hit by global currency depreciation.”

”Revenues hit by global currency depreciation.” Result highlights Ranbaxy’s total income degrew by 9.5% YoY to Rs. 2619 c...

29 Jan 2015 Kisan Ratilal Choksey Shares and Securities Private Limited 7 $58.00

Ranbaxy Labs (RBXY) - Qtr. Update - Dated - January 28, 2015

Ranbaxy Lab’s (Bloomberg: RBXY IN) Q3FY15 revenue at Rs 26 bn (down 10% YoY, 20% QoQ). EBITDA margin declined 503 bps/2,044 b...

29 Jan 2015 Axis Capital Limited 4 $35.00

Ranbaxy Laboratories Limited (RANBAXY) - Financial and Strategic SWOT Analysis Review

Ranbaxy Laboratories Limited (RANBAXY) - Financial and Strategic SWOT Analysis Review Summary Ranbaxy Laboratories Limited (R...

06 Jan 2015 GlobalData 60 $125.00

Ranbaxy Laboratories Limited (RANBAXY) - Financial and Strategic SWOT Analysis Review

Ranbaxy Laboratories Limited (RANBAXY) - Financial and Strategic SWOT Analysis Review Summary Ranbaxy Laboratories Limited (R...

05 Dec 2014 GlobalData 60 $125.00

Ranbaxy Labs - Result Update - "ACCUMULATE" - ”Diovan exclusivity drives earnings.”

”Diovan exclusivity drives earnings.” Revenues - in line but operating margin better than expected Result highlights Ran...

31 Oct 2014 Kisan Ratilal Choksey Shares and Securities Private Limited 6 $58.00